Sfoglia per Autore
Treatment of multiple sclerosis patients after 24 Natalizumab doses: a prospective observational study: the TY-STOP
2014-01-01 Clerico, M; Schiavetti, I; De Mercanti, Sf; Piazza, F; Gned, D; Brescia Morra, V; Lanzillo, R; Ghezzi, A; Bianchi, A; Salemi, G; Realmuto, S; Sola, P; Vitetta, F; Cavalla, P; Superti, G; Ferraro, D; Paolicelli, D; Trojano, M; Sormani, Mp; Durelli, L
How do Treg cell function and related cytokines levels change in alemtuzumab treated patients? A 24 months immunological study
2014-01-01 S De Mercanti ; M Clerico ; S Rolla ; V Bardina ; M.A Cucci ; D Taverna ; D Cimino ; F Piazza ; E Virgilio ; D Armocida ; M Basso ; A Vladic ; M Habek ; I Adamec ; V Brinar ; E Cocco ; J Frau ; P Annovazzi ; D Horàkovà ; I Kovàrovà ; F Novelli ; L Durelli
Natalizumab Therapy, How to Treat How to Stop: The TY-STOP Study
2014-01-01 Clerico, M.; De Mercanti, S.; Piazza, F.; Virgilio, E.; Gned, D.; Brescia Morra, V.; Lanzillo, R.; Amato, L.; Quarantelli, M.; Ghezzi, A.; Bianchi, A.; Baroncini, D.; Salemi, G.; Realmuto, S.; Ferrò, M.T.; Vitetta, F.; Superti, G.; Cavalla, P.; D'Onghia, M.; Paolicelli, D.; Schiavetti, I.; Sormani, M.P.; Pinessi, L.; Trojano, M.; Durelli, L.
Epigenetic therapy for Friedreich ataxia.
2014-01-01 Soragni E;Miao W;Iudicello M;Jacoby D;De Mercanti S;Clerico M;Longo F;Piga A;Ku S;Campau E;Du J;Penalver P;Rai M;Madara JC;Nazor K;O'Connor M;Maximov A;Loring JF;Pandolfo M;Durelli L;Gottesfeld JM;Rusche JR
Treatment of Relapsing-Remitting Multiple Sclerosis After 24 Doses of Natalizumab
2014-01-01 Marinella Clerico;Irene Schiavetti;Stefania F. De Mercanti;Federico Piazza;Dario Gned;Vincenzo Brescia Morra;Roberta Lanzillo;Angelo Ghezzi;Anna Bianchi;Giuseppe Salemi;Sabrina Realmuto;Patrizia Sola;Francesca Vitetta;Paola Cavalla;Damiano Paolicelli;Maria Trojano;Maria Pia Sormani;Luca Durelli
Botulinum Toxin A for Treatment of Sialorrhea in neurologic diseases: 2-year Prospective Study
2015-01-01 Barbero, P; Artusi, Ca; De Mercanti, S; Tinivella, M; Busso, M; Clerico, M; Durelli, L
Are arterial hypertension and diabetes modifiers of ALS phenotype and outcome? A population-based study
2015-01-01 Calvo, A; Moglia, C; Canosa, A; Bertuzzo, D; Galmozzi, F; Cugnasco, P; Clerico, M; De Mercanti, S; Bersano, E; Cammarosano, S; Ilardi, A; Manera, U; Sideri, R; Marinou, K; Bottacchi, E; Pisano, F; Cantello, R; Mazzini, L; Mora, G; Chiò, A
Ultrasound-guided botulinum toxin-A for sialorrhea: a 2-year prospective study
2015-01-01 Artusi, CA; De Mercanti, S; Busso, M; Tinivella, M; Clerico, M; Durelli, L; Barbero, P
Estrogen receptor alpha in peripheral blood lymphocytes of multiple sclerosis patients: a pivotal study of its role in pregnant patients
2015-01-01 Clerico, M; Cutrupi, S; Rolla, S; De Mercanti, S; Iannello, A; Virgilio, E; De Bortoli, M; Durelli, L
Long Term immunological alemtuzumab effect: increase in Tregsuppressor function
2015-01-01 De Mercanti, S; Rolla, S; Cucci, A; Bardina, V; Vacca, A; Cocco, E; Vladic, A; Habek, M; Adamec, I; Horakova, D; Annovazzi, P; Edan, G; Durelli, L; Clerico, M
Atypical Presentation of Progressive Multifocal Leukoencephalopathy in a Natalizumab-treated Patient
2015-01-01 De Mercanti, S; Artusi, Ca; Clerico, M; Iudicello, M; Vacca, A; Virgilio, E; Durelli, L
Estrogen receptor alpha role in multiple sclerosis patients: trying to identify a new biomarker of disease activity
2015-01-01 Clerico, M; Cutrupi, S; De Mercanti, S; Virgilio, E; Iannello, A; De Bortoli, M; Durelli, L
T helper subsets changes in alemtuzumab multiple sclerosis treated patients: the recovery of immune system capacity as a possible indicator to treatment
2015-01-01 De Mercanti, S.F.; Rolla, S.; Cucci, A.; Bardina, V.; Vacca, A.; Cocco, E.; Vladic, A.; Soldo-Butkovic, S.; Habek, M.; Adamec, I.; Horakova, D.; Annovazzi, P.; Edan, G.; Novelli, F.; Durelli, L.; Clerico, M.
Long-term follow-up of ultrasound-guided botulinum toxin-A injections for sialorrhea in neurological dysphagia
2015-01-01 Barbero, P; Busso, M; Tinivella, M; Artusi, Ca; De Mercanti, S; Cucci, A; Veltri, A; Avagnina, P; Calvo, A; Chio', A; Durelli, L; Clerico, M.
Alemtuzumab Long Term Immunological Study: The Immunosuppressive Effect Does Not Last More Than 48 Months
2016-01-01 Durelli, L; De Mercanti, S; Rolla, S; Cucci, A; Bardina, V; Cocco, E; Vladic, A; Soldo-Butkovic, S; Habek, M; Adamec, I; Annovazzi, P; Horakova, D; Novelli, F; Clerico, M
Heterozygous deletion of KLHL1/ATX8OS at the SCA8 locus is unlikely associated with cerebellar impairment in humans
2016-01-01 Mandrile, Giorgia; Di Gregorio, Eleonora; Goel, Himanshu; Giachino, Daniela; De Mercanti, Stefania; Iudicello, Marco; Rolando, Marco; Losa, Sabrina; De Marchi, Mario; Brusco, Alfredo
Alemtuzumab long-lasting immunological effects: a 48 months follow-up observation
2016-01-01 Durelli, L; De Mercanti, SF; Cucci, A; Taverna, D; Rolla, S; Bardina, V; Cocco, E; Vladic, A; Soldo-Butkovic, S; Habek, M; Adamec, I; Horakova, D; Annovazzi, P; Novelli, F; Clerico, M
Estrogen Receptor Alpha Regulates Key Genomic Regions of Thelper 17 and T Regulatory Cells in Multiple Sclerosis: A New Potential Biomarker of Disease Activity
2016-01-01 Clerico, M.; Cutrupi, S.; De Mercanti, S.; Rolla, S.; Iannello, A.; Ferrero, G.; De Bortoli, M.; Durelli, L. .
Estrogen receptor alpha regulates key genomic regions of t-helper 17 and T-regulatory cells in Multiple Sclerosis: a new potential biomarker of disease activity.
2016-01-01 Marinella, Clerico; Santina, Cutrupi; De Mercanti Stefania, ; Simona, Rolla; Andrea, Iannello; Giulio, Ferrero; Bortoli Michele, De; Luca, Durelli
Prognostic influence of pre-morbid smoking habits, diabetes, arterial hypertension and vascular risk profile on phenotype and outcome of ALS patients: a population-based study.
2016-01-01 Bertuzzo, D.; Calvo, A.; Moglia, C.; Canosa, A.; Manera, U.; Ilardi, A.; Cammarosano, S.; Solero, L.; Cugnasco, P.; Clerico, M.; De Mercanti, S.; Marinou, K.; Bottacchi, E.; Mora, G.; Mazzini, L.; Chiò, A. .
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Treatment of multiple sclerosis patients after 24 Natalizumab doses: a prospective observational study: the TY-STOP | 2014 | Clerico, M; Schiavetti, I; De Mercanti, Sf; Piazza, F; Gned, D; Brescia Morra, V; Lanzillo, R; Ghezzi, A; Bianchi, A; Salemi, G; Realmuto, S; Sola, P; Vitetta, F; Cavalla, P; Superti, G; Ferraro, D; Paolicelli, D; Trojano, M; Sormani, Mp; Durelli, L | |
| How do Treg cell function and related cytokines levels change in alemtuzumab treated patients? A 24 months immunological study | 2014 | S De Mercanti ; M Clerico ; S Rolla ; V Bardina ; M.A Cucci ; D Taverna ; D Cimino ; F Piazza ; E Virgilio ; D Armocida ; M Basso ; A Vladic ; M Habek ; I Adamec ; V Brinar ; E Cocco ; J Frau ; P Annovazzi ; D Horàkovà ; I Kovàrovà ; F Novelli ; L Durelli | |
| Natalizumab Therapy, How to Treat How to Stop: The TY-STOP Study | 2014 | Clerico, M.; De Mercanti, S.; Piazza, F.; Virgilio, E.; Gned, D.; Brescia Morra, V.; Lanzillo, R.; Amato, L.; Quarantelli, M.; Ghezzi, A.; Bianchi, A.; Baroncini, D.; Salemi, G.; Realmuto, S.; Ferrò, M.T.; Vitetta, F.; Superti, G.; Cavalla, P.; D'Onghia, M.; Paolicelli, D.; Schiavetti, I.; Sormani, M.P.; Pinessi, L.; Trojano, M.; Durelli, L. | |
| Epigenetic therapy for Friedreich ataxia. | 2014 | Soragni E;Miao W;Iudicello M;Jacoby D;De Mercanti S;Clerico M;Longo F;Piga A;Ku S;Campau E;Du J;Penalver P;Rai M;Madara JC;Nazor K;O'Connor M;Maximov A;Loring JF;Pandolfo M;Durelli L;Gottesfeld JM;Rusche JR | |
| Treatment of Relapsing-Remitting Multiple Sclerosis After 24 Doses of Natalizumab | 2014 | Marinella Clerico;Irene Schiavetti;Stefania F. De Mercanti;Federico Piazza;Dario Gned;Vincenzo Brescia Morra;Roberta Lanzillo;Angelo Ghezzi;Anna Bianchi;Giuseppe Salemi;Sabrina Realmuto;Patrizia Sola;Francesca Vitetta;Paola Cavalla;Damiano Paolicelli;Maria Trojano;Maria Pia Sormani;Luca Durelli | |
| Botulinum Toxin A for Treatment of Sialorrhea in neurologic diseases: 2-year Prospective Study | 2015 | Barbero, P; Artusi, Ca; De Mercanti, S; Tinivella, M; Busso, M; Clerico, M; Durelli, L | |
| Are arterial hypertension and diabetes modifiers of ALS phenotype and outcome? A population-based study | 2015 | Calvo, A; Moglia, C; Canosa, A; Bertuzzo, D; Galmozzi, F; Cugnasco, P; Clerico, M; De Mercanti, S; Bersano, E; Cammarosano, S; Ilardi, A; Manera, U; Sideri, R; Marinou, K; Bottacchi, E; Pisano, F; Cantello, R; Mazzini, L; Mora, G; Chiò, A | |
| Ultrasound-guided botulinum toxin-A for sialorrhea: a 2-year prospective study | 2015 | Artusi, CA; De Mercanti, S; Busso, M; Tinivella, M; Clerico, M; Durelli, L; Barbero, P | |
| Estrogen receptor alpha in peripheral blood lymphocytes of multiple sclerosis patients: a pivotal study of its role in pregnant patients | 2015 | Clerico, M; Cutrupi, S; Rolla, S; De Mercanti, S; Iannello, A; Virgilio, E; De Bortoli, M; Durelli, L | |
| Long Term immunological alemtuzumab effect: increase in Tregsuppressor function | 2015 | De Mercanti, S; Rolla, S; Cucci, A; Bardina, V; Vacca, A; Cocco, E; Vladic, A; Habek, M; Adamec, I; Horakova, D; Annovazzi, P; Edan, G; Durelli, L; Clerico, M | |
| Atypical Presentation of Progressive Multifocal Leukoencephalopathy in a Natalizumab-treated Patient | 2015 | De Mercanti, S; Artusi, Ca; Clerico, M; Iudicello, M; Vacca, A; Virgilio, E; Durelli, L | |
| Estrogen receptor alpha role in multiple sclerosis patients: trying to identify a new biomarker of disease activity | 2015 | Clerico, M; Cutrupi, S; De Mercanti, S; Virgilio, E; Iannello, A; De Bortoli, M; Durelli, L | |
| T helper subsets changes in alemtuzumab multiple sclerosis treated patients: the recovery of immune system capacity as a possible indicator to treatment | 2015 | De Mercanti, S.F.; Rolla, S.; Cucci, A.; Bardina, V.; Vacca, A.; Cocco, E.; Vladic, A.; Soldo-Butkovic, S.; Habek, M.; Adamec, I.; Horakova, D.; Annovazzi, P.; Edan, G.; Novelli, F.; Durelli, L.; Clerico, M. | |
| Long-term follow-up of ultrasound-guided botulinum toxin-A injections for sialorrhea in neurological dysphagia | 2015 | Barbero, P; Busso, M; Tinivella, M; Artusi, Ca; De Mercanti, S; Cucci, A; Veltri, A; Avagnina, P; Calvo, A; Chio', A; Durelli, L; Clerico, M. | |
| Alemtuzumab Long Term Immunological Study: The Immunosuppressive Effect Does Not Last More Than 48 Months | 2016 | Durelli, L; De Mercanti, S; Rolla, S; Cucci, A; Bardina, V; Cocco, E; Vladic, A; Soldo-Butkovic, S; Habek, M; Adamec, I; Annovazzi, P; Horakova, D; Novelli, F; Clerico, M | |
| Heterozygous deletion of KLHL1/ATX8OS at the SCA8 locus is unlikely associated with cerebellar impairment in humans | 2016 | Mandrile, Giorgia; Di Gregorio, Eleonora; Goel, Himanshu; Giachino, Daniela; De Mercanti, Stefania; Iudicello, Marco; Rolando, Marco; Losa, Sabrina; De Marchi, Mario; Brusco, Alfredo | |
| Alemtuzumab long-lasting immunological effects: a 48 months follow-up observation | 2016 | Durelli, L; De Mercanti, SF; Cucci, A; Taverna, D; Rolla, S; Bardina, V; Cocco, E; Vladic, A; Soldo-Butkovic, S; Habek, M; Adamec, I; Horakova, D; Annovazzi, P; Novelli, F; Clerico, M | |
| Estrogen Receptor Alpha Regulates Key Genomic Regions of Thelper 17 and T Regulatory Cells in Multiple Sclerosis: A New Potential Biomarker of Disease Activity | 2016 | Clerico, M.; Cutrupi, S.; De Mercanti, S.; Rolla, S.; Iannello, A.; Ferrero, G.; De Bortoli, M.; Durelli, L. . | |
| Estrogen receptor alpha regulates key genomic regions of t-helper 17 and T-regulatory cells in Multiple Sclerosis: a new potential biomarker of disease activity. | 2016 | Marinella, Clerico; Santina, Cutrupi; De Mercanti Stefania, ; Simona, Rolla; Andrea, Iannello; Giulio, Ferrero; Bortoli Michele, De; Luca, Durelli | |
| Prognostic influence of pre-morbid smoking habits, diabetes, arterial hypertension and vascular risk profile on phenotype and outcome of ALS patients: a population-based study. | 2016 | Bertuzzo, D.; Calvo, A.; Moglia, C.; Canosa, A.; Manera, U.; Ilardi, A.; Cammarosano, S.; Solero, L.; Cugnasco, P.; Clerico, M.; De Mercanti, S.; Marinou, K.; Bottacchi, E.; Mora, G.; Mazzini, L.; Chiò, A. . |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile